Arthrodesis Surgery in India
Get Arthrodesis Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Arthrodesis Surgery in UAE
Arthrodesis Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Arthrodesis, or joint fusion surgery, is a definitive orthopaedic procedure that permanently stabilises a damaged joint by fusing two or more bones, eliminating painful motion caused by severe arthritis, instability, or post-traumatic degeneration. Reported clinical success rates range from 85–95% depending on the joint treated and patient comorbidities, with modern fixation techniques using intramedullary nails, locking plates, and pedicle screw-rod constructs driving consistently high fusion rates. GAF Healthcare connects international patients with JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed centres in Dubai and Abu Dhabi, offering world-class surgical expertise at a fraction of Western costs, with end-to-end concierge support from visa to rehabilitation.
Hospital Stay: 3–7 days (varies by joint: ankle/wrist fusions typically 3–4 days; spinal/subtalar fusions 5–7 days) • Total Stay in Country (Fit-to-Fly): 4–8 weeks (shorter for upper-limb fusions; longer for spinal or lower-limb fusions requiring non-weight-bearing or brace immobilisation; cleared only after surgeon assessment and confirmed absence of DVT risk) • Success Rate: 85–95%
What Is It?
Arthrodesis is the surgical elimination of joint motion by inducing controlled osseous union across a joint surface. The procedure is indicated when articular cartilage is irreparably destroyed — most commonly by end-stage osteoarthritis, rheumatoid arthritis, post-septic arthropathy, avascular necrosis, or post-traumatic malunion — and when pain, instability, or deformity cannot be managed by conservative measures or joint-preserving surgery. The physiological rationale is straightforward: by abolishing pathological micro-motion at the joint interface and converting the articulation into a continuous bony segment, arthrodesis eliminates the nociceptive signals arising from denuded subchondral bone, synovial inflammation, and capsular stretch. The trade-off is permanent loss of range of motion at that joint, which is why patient selection and joint-specific outcome data are central to the pre-operative decision.
The procedure is performed across virtually every joint in the body. Spinal arthrodesis (cervical, thoracic, or lumbar) accounts for the largest volume globally and typically employs pedicle screw-rod instrumentation with autograft or allograft interbody cages, often augmented by recombinant bone morphogenetic protein-2 (rhBMP-2) or synthetic bone substitutes such as beta-tricalcium phosphate. Ankle arthrodesis — the second most common large-joint indication — achieves fusion rates of 90–97% using crossed cancellous screws or retrograde intramedullary nailing. Smaller joint fusions (wrist, subtalar, first metatarsophalangeal, thumb carpometacarpal, interphalangeal) are routinely performed as day-case or short-stay procedures using headless compression screws or mini-fragment locking plates. Advances in intraoperative fluoroscopy, 3D navigation, and computer-assisted surgery (CAS) have substantially improved implant positioning accuracy and reduced revision rates across all joint levels.
The standard of care at GAF Healthcare's partner institutions integrates pre-operative CT-based surgical planning, intraoperative neuromonitoring for spinal cases, multimodal analgesia protocols (regional nerve blocks, NSAIDs, low-dose opioids, gabapentinoids) to minimise opioid burden, and evidence-based venous thromboembolism (VTE) prophylaxis using low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) in line with NICE/AAOS guidelines. Structured physiotherapy commences in the early post-operative period to optimise muscle conditioning around the fused segment and to accelerate functional rehabilitation.
Candidates
• IDEAL CANDIDATES:
• End-stage osteoarthritis of the ankle, wrist, subtalar, midfoot, carpometacarpal, or interphalangeal joints with radiographic joint space obliteration (Kellgren-Lawrence Grade III–IV or equivalent) unresponsive to ≥6 months of conservative therapy (physiotherapy, intra-articular corticosteroids, hyaluronic acid injections, offloading orthotics)
• Rheumatoid or inflammatory arthropathy with severe structural joint destruction despite optimised DMARD/biologic therapy (methotrexate, TNF-inhibitors, JAK inhibitors)
• Degenerative or isthmic spondylolisthesis (Grade II or above), lumbar spinal stenosis with instability, or recurrent disc herniation with segmental instability requiring spinal fusion
• Post-traumatic arthritis following malunited intra-articular fractures, Lisfranc injuries, or calcaneal fractures
• Avascular necrosis (AVN) with subchondral collapse and secondary arthrosis (e.g., lunate AVN / Kienböck disease; navicular AVN / Müller-Weiss disease)
• Charcot neuroarthropathy (neuropathic joint destruction) — particularly midfoot/hindfoot in diabetic patients — requiring structural reconstruction and stabilisation
• Septic arthritis sequelae with destroyed cartilage and fibrous non-union after infection eradication
• Failed prior joint replacement (total ankle, total wrist, MCP joint arthroplasty) requiring salvage arthrodesis
• Severe hallux valgus or hallux rigidis (first MTP arthrodesis) unresponsive to joint-preserving procedures
• REQUIRED DIAGNOSTIC WORKUP:
• Weight-bearing plain radiographs (AP, lateral, oblique) of the affected joint — mandatory baseline
• CT scan (often with 3D reconstruction) for detailed bone stock assessment, deformity analysis, and pre-operative templating
• MRI of the affected joint — to evaluate cartilage, bone marrow oedema, soft tissue integrity, and rule out occult infection or AVN
• Bone density (DEXA scan) — to assess osteoporosis risk and implant anchorage quality (especially in spinal and large-joint cases)
• Inflammatory markers: ESR, CRP, WBC with differential — to exclude active infection before elective fusion
• Haematological and biochemical panel: FBC, renal function, liver function, coagulation profile (PT/INR/aPTT), HbA1c (diabetic patients), serum albumin (nutritional status)
• Vascular assessment: ankle-brachial index (ABI) and/or Doppler ultrasound for lower-limb fusions in patients with peripheral artery disease or diabetes
• Bone SPECT or Tc-99m bone scan — to confirm joint-level activity and identify adjacent joint degeneration in complex hindfoot/midfoot cases
• Cardiac evaluation (ECG, ECHO, stress test) for patients over 60 or with known cardiovascular comorbidities, per anaesthesia risk stratification (ASA/Lee Revised Cardiac Risk Index)
• Pulmonary function tests (spirometry) for spinal fusion candidates requiring prolonged general anaesthesia
• RELATIVE AND ABSOLUTE CONTRAINDICATIONS:
• Active osteomyelitis or septic arthritis at the operative site (must be fully eradicated and confirmed bacteriologically before elective fusion)
• Severely compromised soft tissue envelope or active skin ulceration overlying the planned surgical field
• Peripheral vascular disease with ABI < 0.5 or critical limb ischaemia (high wound complication and non-union risk)
• Uncontrolled diabetes mellitus (HbA1c > 9%) — substantially increases non-union, infection, and Charcot progression risk
• Active tobacco smoking (relative contraindication; strongly associated with non-union — patients counselled to cease smoking ≥6 weeks pre-operatively)
• Severe osteoporosis (T-score < −3.5) without optimisation of bone quality (bisphosphonate therapy, vitamin D/calcium supplementation) — implant purchase may be insufficient
• Uncontrolled systemic inflammatory disease requiring high-dose immunosuppression (biological DMARDs typically withheld 4–5 half-lives pre-operatively)
• Significant psychological contraindications or unrealistic patient expectations regarding residual stiffness and functional limitations post-fusion
• Adjacent segment disease risk must be thoroughly counselled for spinal fusion candidates
Procedure
STANDARD OPEN ARTHRODESIS:
The traditional open technique involves formal arthrotomy, thorough decortication of the joint surfaces to expose bleeding cancellous bone (the biological prerequisite for osseous union), and rigid internal fixation to provide mechanical stability during the 12–16 week fusion window. Fixation constructs vary by joint:
• Ankle arthrodesis: crossed 6.5–7.3 mm cancellous cannulated screws (two or three-screw construct) or retrograde intramedullary nail (Biomet, Smith & Nephew TRIGEN HERO, Stryker T2 Ankle nail) — the nail construct is preferred for patients with significant bone loss, revision cases, or Charcot neuroarthropathy
• Subtalar arthrodesis: single large cancellous screw or two-screw construct; retrograde subtalar nail in complex hindfoot deformity
• Wrist (radiocarpal/pancarpal) arthrodesis: straight locking fusion plate (AO/Synthes Wrist Fusion Plate) with supplementary bone graft
• Spinal arthrodesis (PLIF/TLIF/ALIF/XLIF): pedicle screw-rod constructs with PEEK or titanium interbody cages packed with autograft, allograft, or synthetic bone substitute; supplemented with demineralised bone matrix (DBM) or rhBMP-2 where appropriate
• First MTP arthrodesis (hallux rigidis): crossed cancellous screws or low-profile locking dorsal plate (Arthrex, Stryker StepTech)
• Thumb CMC arthrodesis: K-wire and tension-band or mini-locking plate
MINIMALLY INVASIVE ARTHROSCOPIC ARTHRODESIS:
Arthroscopic fusion has become the gold standard for ankle and subtalar arthrodesis at high-volume centres, replacing open surgery for the majority of primary (non-revision) cases. Key advantages include reduced soft tissue trauma, lower wound complication rates, shorter hospital stay, and equivalent or superior fusion rates (92–97%). Technique involves portal-based joint preparation using motorised shavers and burrs, fluoroscopic or navigation-guided screw placement, and optional arthroscopic bone grafting. Hindfoot endoscopy (two-portal posterior approach) is used for isolated subtalar arthrodesis.
COMPUTER-ASSISTED SURGERY (CAS) AND 3D NAVIGATION:
Intraoperative 3D navigation (Brainlab, Stryker NAV3i, Medtronic StealthStation) is routinely used for complex spinal fusions and deformity correction cases to achieve sub-millimetre pedicle screw placement accuracy and reduce revision rates. Navigation reduces intraoperative radiation exposure compared with repeated fluoroscopy.
ROBOTIC-ASSISTED SPINAL FUSION:
Systems such as the Mazor X Stealth Edition (Medtronic) and ROSA Spine (Zimmer Biomet) provide robotic guidance for pedicle screw trajectory planning and execution, with clinical studies demonstrating screw accuracy of >98% and statistically significant reductions in revision surgery. GAF Healthcare's partner centres in India and the UAE operate both platforms.
BIOLOGIC AUGMENTATION STRATEGIES:
• Autologous iliac crest bone graft (ICBG): the gold standard bone graft source for high-risk non-union cases (smoking, diabetes, revision fusion, large defects); harvested from the anterior or posterior iliac crest
• Allograft (freeze-dried or fresh-frozen): avoids donor site morbidity; used extensively in spinal interbody cages and bulk defect filling
• Recombinant human BMP-2 (Infuse, Medtronic) / BMP-7 (OP-1): growth factor augmentation in posterolateral and interbody spinal fusion; particularly valuable in high-risk non-union patients
• Beta-tricalcium phosphate (β-TCP) ceramics and biphasic calcium phosphate: osteoconductive synthetic scaffolds used as graft extenders
• Platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC): adjuncts under investigation; evidence is emerging for peripheral joint fusions
ELECTRICAL STIMULATION FOR RECALCITRANT NON-UNION:
For patients with established non-union or high-risk biology, pulsed electromagnetic field (PEMF) devices or direct current bone stimulators (Biomet EBI, DJO Orthofix) are used as adjunctive therapies to promote osteogenesis, supported by Level II clinical evidence.
PHARMACOLOGICAL OPTIMISATION (PRE- AND POST-OPERATIVE):
• Pre-operative anabolic therapy: teriparatide (PTH 1-34) or abaloparatide may be prescribed 3–6 months pre-operatively in severely osteoporotic patients to improve bone quality before fusion
• Post-operative: NSAIDs are generally avoided for the first 6–8 weeks post-fusion as COX-2 inhibition may impair osteogenesis; selective use of celecoxib for breakthrough pain must be carefully balanced
• Bisphosphonates: withheld in the early post-fusion period; typically resumed after radiographic union is confirmed
Cost of Arthrodesis Surgery: India vs. UAE
Arthrodesis surgery costs vary considerably depending on the joint fused, the number of spinal levels involved, implant complexity (standard screws versus robotic navigation, biologic bone graft augmentation), and hospital tier. India offers the most cost-efficient access to internationally accredited, high-volume orthopaedic expertise, with total package costs typically 50–65% lower than comparable procedures in the UAE, and 70–80% lower than Western Europe or North America. The following figures represent all-inclusive estimates (surgeon fee, anaesthesia, implants, hospital stay, physiotherapy, and standard investigations) for primary single-joint arthrodesis. Complex multi-level spinal fusions or revision procedures carry higher costs and are quoted individually after case review.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $3,500 – $12,000 | ~53% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $8,000 – $25,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — PRE-OPERATIVE PLANNING (4–8 WEEKS BEFORE ARRIVAL):
• GAF Healthcare coordinators collect medical records, imaging (X-rays, CT, MRI in DICOM format), and laboratory results
• Remote teleconsultation with the treating orthopaedic surgeon at the partner hospital for case review, surgical planning, and implant selection
• Pre-operative CT-based 3D reconstruction and surgical templating completed; patient-specific instrumentation (PSI) ordered if required for complex deformity correction
• Medical optimisation: anaemia correction (IV iron or EPO if Hb < 10 g/dL), glycaemic control (target HbA1c < 7.5% for elective cases), smoking cessation (minimum 6 weeks), bisphosphonate holiday (if applicable), and biologic DMARD washout per drug half-life
• Cardiac and pulmonary clearance obtained; anaesthesia risk stratified (ASA classification)
• e-Medical visa application (India) or visa-on-arrival/UAE entry visa facilitated by GAF Healthcare
• Patient and one attendant booked into hospital-adjacent serviced apartment or recovery guesthouse
PHASE 2 — ARRIVAL AND FINAL PRE-OPERATIVE ASSESSMENT (1–3 DAYS BEFORE SURGERY):
• GAF Healthcare driver meets patient at airport; wheelchair or mobility aid arranged as required
• Hospital admission for final blood tests, repeat weight-bearing radiographs, anaesthesia pre-assessment, and consent
• Orthopaedic surgeon and anaesthetist review; surgical site marked; VTE risk stratified (Caprini score); LMWH prophylaxis prescribed
• Bowel prep (spinal cases) and skin antisepsis protocol initiated
• Patient and family counselled on expected post-operative limitations, cast/brace requirements, and weight-bearing restrictions
PHASE 3 — SURGERY (DAY 0):
• General or regional anaesthesia (spinal/epidural block preferred for ankle, subtalar, and foot fusions to reduce systemic opioid load)
• Intraoperative neuromonitoring (SSEP, MEP) for all spinal arthrodesis cases
• Joint surfaces prepared: cartilage excised, subchondral bone fenestrated or fishscaled to maximise bleeding cancellous bone contact area
• Reduction of deformity (if present) and provisional fixation with K-wires under fluoroscopic confirmation
• Definitive implant placement (screws, plate, nail, or pedicle screw-rod construct as planned)
• Bone graft placement (autograft, allograft, synthetic, or biologic augment per pre-operative plan)
• Wound closure in layers; drain placed for large-joint and spinal cases; sterile dressing applied
• Typical operative duration: 45–90 minutes (peripheral joint); 2–5 hours (spinal fusion, multi-level or deformity cases)
PHASE 4 — IMMEDIATE POST-OPERATIVE CARE (DAYS 1–5):
• Recovery room: haemodynamic monitoring, pain management with multimodal analgesia (paracetamol IV, ketorolac short course, regional block top-up, low-dose opioid PRN), anti-emetics
• Day 1: physiotherapist assessment; upper-limb and non-operative limb exercises commenced; respiratory physiotherapy for spinal fusion patients
• Non-weight-bearing (NWB) mobilisation with crutches or walker initiated for lower-limb fusions; spinal fusion patients mobilised upright on Day 1 under physiotherapist supervision
• Drain removal (Day 1–2); wound inspection
• LMWH VTE prophylaxis continued; transitioned to DOAC (rivaroxaban or apixaban) on discharge per protocol
• Discharge from hospital: Day 3–4 for peripheral joint fusions; Day 5–7 for spinal fusions
PHASE 5 — IN-COUNTRY RECOVERY AND REHABILITATION (WEEKS 1–6):
• Patient recovers at partner recovery accommodation with daily or alternate-day physiotherapy sessions
• Wound review and suture/staple removal at 10–14 days
• Radiographic check (plain X-ray or CT) at 4–6 weeks to confirm early callus formation and implant position
• Weight-bearing progression for ankle/hindfoot fusion: NWB cast for 6 weeks → protected weight-bearing in walking boot (Weeks 6–12) → progressive full weight-bearing (Weeks 12–16)
• Spinal fusion patients: TLSO brace worn for 6–12 weeks; progressive ambulation and spinal physiotherapy; return to sedentary work at 6–8 weeks
• Upper-limb fusion (wrist, thumb CMC): thermoplastic splint; grip strengthening commences at 6–8 weeks
• FIT-TO-FLY ASSESSMENT: Surgeon reviews wound healing, X-ray, and VTE risk at 4–6 weeks (peripheral joint) or 6–8 weeks (spinal). Long-haul flight cleared only after confirmed absence of DVT (duplex ultrasound if clinical suspicion), stable wound, and adequately managed pain. Patients advised to wear compression stockings, maintain hydration, and perform in-seat calf exercises during flight.
PHASE 6 — LONG-TERM RECOVERY (MONTHS 3–12, MANAGED REMOTELY WITH HOME PHYSIOTHERAPIST):
• Radiographic fusion confirmation: CT scan at 3–4 months for complex fusions; plain X-ray suffices for small joint cases
• Full osseous union expected at 4–6 months for peripheral joints; 6–12 months for multi-level spinal fusions
• Return to low-impact sports (cycling, swimming): typically at 6–9 months post ankle/hindfoot fusion
• Remote follow-up via telemedicine with GAF Healthcare's partner surgeon at 3, 6, and 12 months post-operatively
Risks & Considerations
Arthrodesis is a high-efficacy procedure with a well-characterised risk profile that patients must understand prior to informed consent. Non-union (failure of the bones to fuse) is the most clinically significant complication, occurring in 5–10% of primary fusions and rising to 15–25% in high-risk patients (active smokers, uncontrolled diabetics, severe osteoporosis, or revision surgery). Persistent non-union may require re-operation with repeat bone grafting, exchange of implants, or augmentation with electrical bone stimulation. Hardware-related complications — including implant prominence causing pain, screw back-out, or plate irritation — occur in approximately 5–15% of cases and frequently necessitate elective hardware removal after confirmed union. Wound infection (superficial or deep) is reported in 1–3% of cases; deep infection after spinal fusion is particularly morbid and may require surgical debridement and prolonged intravenous antibiotic therapy (6 weeks). Neurovascular injury risk is procedure-specific: ankle arthrodesis carries a small risk of sural or superficial peroneal nerve injury (<3%); spinal arthrodesis carries risks of dural tear (1–3%), nerve root injury (<1%), and, in cervical cases, rare vertebral artery or spinal cord injury. Venous thromboembolism (DVT and pulmonary embolism) risk is elevated for all lower-limb and spinal procedures; pharmacological prophylaxis and early mobilisation reduce — but do not eliminate — this risk. Adjacent segment degeneration is a well-recognised long-term consequence of spinal arthrodesis, with radiographic evidence appearing in 30–40% of patients at 10 years, though symptomatic disease requiring further intervention is less common. Patients undergoing ankle or hindfoot fusion should be counselled that altered biomechanics accelerate wear on the subtalar, talonavicular, and ipsilateral knee joints over the ensuing decades. Malposition (fusion in non-optimal alignment) can result in persistent pain, gait abnormality, or transfer metatarsalgia and is best prevented through meticulous intraoperative technique and fluoroscopic confirmation. Anaesthetic risks are stratified by the patient's ASA classification and are thoroughly assessed during pre-operative workup. All patients should disclose their complete medication list, particularly anticoagulants, antiplatelets, immunosuppressants, and bisphosphonates, as these interact directly with surgical safety and bone healing biology.
Top Hospitals for Arthrodesis Surgery
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
Manipal Hospitals
Bengaluru, India
Manipal Hospitals Dwarka
New Delhi, India
Burjeel Hospital for Advanced Surgery Dubai
Dubai, UAE
Kings College Hospital Dubai
Dubai, UAE
Top Doctors for Arthrodesis Surgery
Internationally trained specialists in Orthopedics. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. H. Vinay Kumar
MBBS, MS, Fellowship in Arthroscopy & Sports Medicine, Fellowship in Joint Replacement
Orthopedic Surgeon
Yashoda Hospitals, Secunderabad, Hyderabad, India
10+ Yearsof experience
Dr. H. Vinay Kumar is a Senior Consultant Orthopedic Surgeon at Yashoda Hospitals in Secunderabad, Hyderabad, with over 10 years of clinical experience in advanced joint surgery and arthroscopy. He holds an MS in Orthopedics from SCB Government Medical College, Cuttack, and has completed specialized fellowships in Arthroscopy & Sports Medicine (Ahmedabad) and Joint Replacement (Hyderabad), positioning him at the forefront of minimally invasive orthopedic… Read more
Dr. Hemant Sharma
MBBS, DNB (Orthopaedics), MRCS (England), FRCS (England)
Orthopedic Surgeon
Marengo Asia Hospitals, Gurugram, India
28+ Yearsof experience
Dr. Hemant Sharma is Chairman of Orthopaedics & Joint Replacement and Spine Surgery at Marengo Asia Hospitals in Gurugram, bringing over 28 years of clinical expertise to orthopedic surgery. A Fellow of the Royal College of Surgeons of England and holder of a postgraduate DNB in Orthopaedics, Dr. Sharma trained extensively in both India and England, spending 11 years in each country to refine his surgical craft. His academic foundation began with an MBBS… Read more
Dr. Jitendra Kataria
MBBS, D Ortho, DNB Ortho, Fellowship in Arthroplasty, Diploma in Medico-Legal Systems
Orthopedic Surgeon
Gleneagles Global Hospitals, Mumbai, India
10+ Yearsof experience
Dr. Jitendra Kataria is a Consultant Orthopedic Surgeon at Gleneagles Global Hospitals in Mumbai with over 10 years of dedicated clinical experience. He holds a comprehensive postgraduate pedigree, including a DNB in Orthopaedics from P. D. Hinduja Hospital and a specialized Fellowship in Arthroplasty. His advanced training equips him with technical proficiency across the full spectrum of orthopedic care. Dr. Kataria's clinical expertise spans complex… Read more
Dr. Karthik Gajapathy
MBBS, DNB (Ortho)
Orthopedic Surgeon
Gleneagles Hospitals, Bengaluru, India
25+ Yearsof experience
Dr. Karthik Gajapathy is a Senior Consultant in Orthopedic Surgery with over 25 years of dedicated clinical practice in Bengaluru, India. Holding qualifications in MBBS and DNB (Orthopedics), he has established himself as a compassionate and highly skilled practitioner in joint replacement and orthopedic trauma care. His extensive experience spans the full spectrum of orthopedic conditions, from degenerative joint disease to complex fracture management.… Read more
Dr. M N Sehar
MBBS, MS, Dip.Orth, FRCS, FRCS Orth (UK)
Orthopedic Surgeon
Indraprastha Apollo Hospital, New Delhi, India
30+ Yearsof experience
Dr. M N Sehar is a Senior Consultant in Orthopedic Surgery at Indraprastha Apollo Hospital in New Delhi, bringing over 30 years of dedicated experience in musculoskeletal care. He holds prestigious qualifications including MBBS, MS, Dip.Orth, FRCS, and FRCS Orth (UK) from the Royal College of Surgeons—reflecting his rigorous training across India and the United Kingdom. His clinical focus spans advanced joint replacement surgery, arthroscopic techniques,… Read more
Patient Success Story
Frequently Asked Questions — Arthrodesis Surgery
The total cost of arthrodesis surgery depends primarily on which joint is being fused, the complexity of fixation (number of spinal levels, implant type, whether biologic bone graft augmentation such as rhBMP-2 is used), and the tier of hospital selected. As a comprehensive guide: in India, a single peripheral joint fusion (ankle, wrist, subtalar, or small foot/hand joints) at a JCI- or NABH-accredited hospital typically costs USD 3,500–7,500 all-inclusive (surgery, implants, anaesthesia, 3–5 days hospital stay, physiotherapy, and standard investigations). A single-level lumbar or cervical spinal fusion ranges from USD 6,000–12,000 in India. In the UAE (Dubai or Abu Dhabi) at a JCI- or DHA-licensed centre, the same peripheral joint arthrodesis ranges from USD 8,000–14,000, and single-level spinal fusion from USD 15,000–25,000. Multi-level spinal fusions or revision arthrodesis procedures carry higher costs in both destinations and are individually quoted after a thorough case review by GAF Healthcare's partner surgeons. India offers cost savings of 50–65% compared with the UAE and 70–80% compared with the United Kingdom, United States, or Australia for equivalent procedures. All GAF Healthcare packages include pre-operative consultations, surgery, hospital accommodation, standard medications, physiotherapy, and post-discharge follow-up visits; international flights, personal accommodation, and travel insurance are arranged separately.
The minimum safe in-country stay before international air travel depends on which joint has been fused. For upper-limb fusions (wrist, thumb CMC, finger interphalangeal joints), fit-to-fly clearance is typically granted at 3–4 weeks post-operatively, provided wound healing is confirmed and the patient can manage the flight in a splint or cast. For ankle, subtalar, or midfoot fusions, a minimum of 5–6 weeks in-country is recommended; patients remain non-weight-bearing in a cast for the first 6 weeks, and the immobility and dependent limb position during a long-haul flight significantly elevate DVT risk until the early healing phase is established. For single-level lumbar or cervical spinal fusion, most surgeons clear patients for long-haul flight at 5–7 weeks, after a check X-ray confirms satisfactory implant position and early bridging callus, and provided there are no wound complications. Multi-level spinal fusions typically require 7–8 weeks minimum. Critically, fit-to-fly clearance is made on an individual basis by the operating surgeon and is not granted automatically at a fixed time point — patients with diabetes, obesity, peripheral vascular disease, or prior DVT require duplex ultrasound DVT screening before flight approval. GAF Healthcare schedules the fit-to-fly surgical review, arranges the required imaging, and assists with booking flexible return flights to accommodate the actual clearance date. All patients are provided with written flight instructions including compression stocking grade, hydration advice, in-seat lower-limb exercises, and LMWH injection protocol for the flight day.
The overall clinical success rate of arthrodesis surgery — defined as achieving solid osseous fusion, clinically significant pain relief (VAS improvement ≥4 points or AOFAS/ODI score improvement ≥40%), and patient satisfaction — ranges from 85–95% across all joint types in the published peer-reviewed literature. Success rates are highest for first metatarsophalangeal (MTP) arthrodesis (92–97% fusion rate), ankle arthrodesis performed arthroscopically at high-volume centres (90–97%), and single-level lumbar interbody fusion with pedicle screw fixation (85–95% fusion rate, 70–80% satisfactory functional outcome). Non-union — the principal mode of failure — occurs in 5–10% of primary fusions in standard-risk patients. This rises to 15–25% in high-risk populations: active smokers (nicotine impairs osteoblastic activity and local microcirculation), poorly controlled diabetics (HbA1c > 9%), patients with severe osteoporosis (T-score < −3.5), and revision surgery cases. GAF Healthcare's partner hospitals are selected on the basis of audited outcome data: only centres performing a minimum of 150 arthrodesis procedures annually with documented fusion rates at or above national registry benchmarks are included in the network. Intraoperative technologies including robotic guidance (Mazor X, ROSA Spine), 3D navigation, and the use of validated biologic augments (rhBMP-2, BMAC) at these centres contribute to above-average fusion rates. Patients are counselled that while pain relief is the primary outcome goal, arthrodesis permanently eliminates motion at the fused joint; functional satisfaction is highest when patient expectations are accurately set through thorough pre-operative counselling.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides a comprehensive medical tourism concierge service for every patient travelling to India or the UAE for arthrodesis surgery, removing administrative and logistical barriers so patients can focus entirely on recovery.
INDIA — VISA AND ENTRY: GAF Healthcare facilitates the Indian e-Medical Visa (e-MV), which is available to nationals of over 160 countries and can be obtained within 72 hours of application. The e-MV is valid for 60 days and permits multiple entries, accommodating patients who require a pre-operative visit and a subsequent surgery trip. A companion e-Medical Attendant Visa is simultaneously processed for one accompanying family member or caregiver. GAF Healthcare provides the hospital invitation letter — a mandatory document for the visa application — and supports patients in compiling the medical records package required by the Indian High Commission or Embassy.
UAE (DUBAI / ABU DHABI) — VISA AND ENTRY: Nationals of over 120 countries receive a visa-on-arrival or visa-free entry to the UAE, valid for 14–90 days depending on passport nationality, which comfortably covers the required in-country recovery period for most arthrodesis procedures. For nationals from visa-required countries, GAF Healthcare arranges a UAE medical treatment visa through the General Directorate of Residency and Foreigners Affairs (GDRFA), using the hospital's treatment confirmation letter and patient medical summary. The process typically takes 3–5 working days.
AIRPORT TRANSFERS AND IN-COUNTRY MOBILITY: GAF Healthcare arranges private, accessible vehicle transfers between the airport and hospital for arrival and departure, with wheelchair assistance and luggage support for patients with lower-limb or spinal conditions. For the duration of in-country recovery, accessible transportation to and from physiotherapy sessions, outpatient appointments, and wound clinics is coordinated through the GAF Healthcare patient app and dedicated coordinator.
DEDICATED PATIENT COORDINATOR AND TRANSLATION: Each patient is assigned a named GAF Healthcare patient coordinator who speaks the patient's language (available in English, Arabic, Russian, Hindi, Swahili, and French among others) and serves as the single point of contact for all hospital, insurance, and logistics queries. Medical interpreters are available in person or via secure video link for all clinical consultations — critical for accurate informed consent and post-operative instruction. Written discharge summaries, rehabilitation plans, and prescription documents are translated into the patient's language before departure.
ACCOMMODATION FOR PATIENT AND ATTENDANT: GAF Healthcare has negotiated rates at serviced apartments, hotel apartments, and medical recovery homes within 1–3 km of all partner hospitals. Accommodation options are graded (standard, premium, and luxury) to accommodate all budgets. All properties offer accessible bathrooms, ground-floor or lift access, and housekeeping — essential for patients in non-weight-bearing casts or spinal braces. Meal delivery services, including dietitian-reviewed post-surgical menus (high-protein for wound healing and bone union) are available at all accommodation partners.
INSURANCE AND FINANCIAL DOCUMENTATION: GAF Healthcare provides itemised pro-forma invoices and detailed surgical reports in the format required by international health insurers for reimbursement claims. Patients are advised to obtain medical travel insurance that explicitly covers orthopaedic surgery and any required post-operative extension of stay before departure.